Company Directory - Clinical Research
We help our clients address their drug development needs by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider.
Novavax, Inc. (Nasdaq:NVAX) is a late-stage biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
Novotech is internationally recognized as the leading regional full-service Contract Research Organization (CRO). Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies.
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.
Nucleus Network is Australia’s largest Phase 1 clinical research organization and the only Phase 1 specialist globally with facilities in the USA and Australia. Since our establishment in 2004, Nucleus Network has conducted well over 1000 Phase 1 clinical trials for Biotechnology and Pharmaceutical Companies from across the globe.
PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and is known to be highly selective about the work that they pursue.
Paratus Clinical was established to meet the increasing need for efficient, cost effective and quality delivery of clinical trials within Australia. By sitting outside of the Public Health system, Paratus can respond to client needs quickly and improve the speed of delivery of your trial.
PharSafer® is a specialist Global CRO focusing on Pharmacovigilance & Medical Services. Formed in 2002 and Headquartered in the UK, PharSafer® has enjoyed continued annual client growth, global expansion and increased staffing.
Pharmalys is a trusted Niche Contract Research Organisation (CRO) based in the UK and in Senegal. We have the expertise to manage your entire project from feasibility to reporting. Alternatively, we can offer stand-alone services, giving you just the level of assistance you require to complement your in-house competencies.
PHASTAR is a global CRO offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP style arrangements and preferred partnerships.
Our founder, Dr. Ibrahim Farr, launched Pivotal to share and implement scientific strategies and best project practices that make clinical trials more efficient and maximize our client’s drug development programmes.
Premier Research helps highly innovative bio-pharmaceutical and medical device companies transform life-changing ideas into reality. We place a special focus on unmet needs in such areas as analgesia, CNS, rare diseases and pediatric research.
Quanticate is one of the world’s largest global data-focused Clinical Research Organisation (CRO) also known as a ‘Biometric CRO’. We are primarily focused on data capture, statistical analysis, and clinical trial reporting.
Science 37 enables universal access to clinical research—making it easier for patients and providers to participate and accelerating the development of new and innovative treatments that impact patient lives.
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently generate quality evidence for clinical studies across traditional, virtual, and hybrid trial models.
Simbec-Orion is a full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases. We provide full-service clinical development solutions for small and mid-size drug developers.
